Table 4 Univariate analysis for severe complications after PE
Characteristic | Percentage | P-value |
|---|---|---|
Age, y | ||
 < 60 | 21.6% | 0.569 |
 ≥ 60 | 0 | |
History of radiotherapy | ||
 Yes | 21.6% | 0.569 |
 No | 0 | |
History of surgery | ||
 Yes | 27.3% | 0.249 |
 No | 10.5% | |
Presence of comorbidity | ||
 Yes | 14.3% | 0.692 |
 No | 22.2% | |
Year of surgery | ||
 2016 or earlier | 37.5% | 0.040 |
 After 2016 | 8.0% | |
Lymphotomy | ||
 Yes | 22.2% | 0.692 |
 No | 14.3% | |
Scope of surgery | ||
 Total PE | 23.3% | 0.412 |
 Anterior PE and posterior PE | 9.1% | |
Surgical duration, min | ||
 ≤ 480 | 12.0% | 0.225 |
 > 480 | 31.3% | |
Maximum tumor diameter, cm | ||
 < 4 | 31.3% | 0.235 |
 ≥ 4 | 13.0% | |
Pelvic wall resection | ||
 Yes | 18.8% | 1.000 |
 No | 20.0% | |